RaySearch establishes North American sales organization

RaySearch establishes North American sales organization

RaySearch Laboratories AB (publ.) has formed a US subsidiary named
RaySearch Americas Inc. The new company will be located in New York and
will market RaySearch's treatment planning system RayStation® in the
North American market. This will include sales as well as service,
clinical support and input into product development based on the North
American experience. RaySearch Americas will also support the first
clinical implementation of RayStation® in the US, which is currently
taking place at Massachusetts General Hospital in Boston.

“We started marketing RayStation® from Sweden in 2010 when we received
510(k) clearance. As we now have the first reference customer up and
running and see considerable interest from other clinics in North
America, we feel the timing is right to set up our own US sales and
service organization to fulfill our customers' needs in the best
possible way. This is a logical step in our evolution but nevertheless a
significant strategic milestone for RaySearch,” says Johan Löf, CEO of
RaySearch.

To lead the sales and support effort, Marc Mlyn has been recruited as
President and CEO of RaySearch Americas, and David McPhail as Vice
President of Sales. Both have a long history in the radiation oncology
industry, particularly in the area of radiation therapy planning. Marc
Mlyn spent more than a decade building up and leading the ADAC/Philips
Radiation Oncology Systems' worldwide support organization. He joins
RaySearch from CIVCO where he was the Vice President of Marketing and
Product Development. David McPhail began his career in radiation therapy
handling strategic accounts for ADAC/Philips and eventually became the
Vice President of Oncology sales for all of North America. He also comes
from CIVCO where he served in the same capacity.

“I am excited to have the opportunity to take part in the introduction
of RaySearch's treatment planning system into this market. RaySearch
Laboratories has a long and successful history in radiation therapy
algorithms and software products. We believe that with the existing
large and dedicated development organization we can provide cutting edge
treatment planning functionality that is both pertinent and accessible
to all radiation therapy departments”, says Marc Mlyn.

David McPhail adds: “There is a place for best-in-class solutions in
radiation therapy departments. Given the right products that meet
customer needs, combined with world class customer service and true
clinical partnership, RaySearch Americas can fill a much needed role in
our business.”

“I am very happy that Marc and David are joining us and I am convinced
that their talent and vast experience will be instrumental for
establishing RayStation® as the leading treatment planning system in the
North American market,” concludes Johan Löf.

RayStation® integrates all RaySearch's advanced treatment planning
solutions into one flexible treatment planning system. It combines
unique features such as multi-criteria optimization tools with full
support for 4D adaptive radiation therapy. It also includes
functionality such as RaySearch's market-leading algorithms for IMRT and
VMAT optimization and highly accurate dose engines for both photon and
proton therapy. The system is built on the latest software architecture
and has a graphical user interface offering state-of-the-art usability.

About RaySearch
RaySearch Laboratories is a medical technology company that develops
advanced software solutions for improved radiation therapy of cancer.
RaySearch's products are mainly sold through license agreements with
leading partners such as Philips, Varian, Siemens, Nucletron, IBA
Dosimetry and TomoTherapy. To date, 15 products have been launched
through partners and RaySearch's software is used at some 1,500 clinics
in more than 30 countries. In addition, RaySearch offers the proprietary
treatment planning system RayStation® directly to clinics. RaySearch was
founded in 2000 as a spin-off from Karolinska Institutet in Stockholm
and the company is listed in the Small Cap segment on NASDAQ OMX
Stockholm.

For more information about RaySearch, visit
www.raysearchlabs.com (http://www.raysearchlabs.com/).

 

 

For further information, contact:
Johan Löf, President and CEO, RaySearch Laboratories AB
Telephone: +46 (0)8-545 061 30
johan.lof@raysearchlabs.com (johan.lof@raysearchlabs.com)